Your browser doesn't support javascript.
loading
CD70, a novel target of CAR T-cell therapy for gliomas.
Jin, Linchun; Ge, Haitao; Long, Yu; Yang, Changlin; Chang, Yifan Emily; Mu, Luyan; Sayour, Elias J; De Leon, Gabriel; Wang, Qiong J; Yang, James C; Kubilis, Paul S; Bao, Hongbo; Xia, Songsong; Lu, Dunyue; Kong, Yingjun; Hu, Li; Shang, Yujiao; Jiang, Chencheng; Nie, Jing; Li, Shimin; Gu, Yunhe; Sun, Jiahang; Mitchell, Duane A; Lin, Zhiguo; Huang, Jianping.
Afiliación
  • Jin L; UF Brain Tumor Immunotherapy Program, Preston A. Wells Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, Florida, USA.
  • Ge H; Fourth Section of the Department of Neurosurgery, the First Affiliated Hospital, Harbin Medical University(HMU), Harbin, China.
  • Long Y; Fourth Section of the Department of Neurosurgery, the First Affiliated Hospital, Harbin Medical University(HMU), Harbin, China.
  • Yang C; UF Brain Tumor Immunotherapy Program, Preston A. Wells Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, Florida, USA.
  • Chang YE; Fourth Section of the Department of Neurosurgery, the First Affiliated Hospital, Harbin Medical University(HMU), Harbin, China.
  • Mu L; UF Brain Tumor Immunotherapy Program, Preston A. Wells Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, Florida, USA.
  • Sayour EJ; UF Brain Tumor Immunotherapy Program, Preston A. Wells Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, Florida, USA.
  • De Leon G; Laboratory of Molecular and Cellular Neuroscience, Rockefeller University, New York, New York, USA.
  • Wang QJ; Fourth Section of the Department of Neurosurgery, the First Affiliated Hospital, Harbin Medical University(HMU), Harbin, China.
  • Yang JC; UF Brain Tumor Immunotherapy Program, Preston A. Wells Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, Florida, USA.
  • Kubilis PS; UF Brain Tumor Immunotherapy Program, Preston A. Wells Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, Florida, USA.
  • Bao H; Duke University Medical Center, Department of Surgery, Division of Applied Therapeutics, Durham, North Carolina, USA.
  • Xia S; Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Lu D; Oncology Research, MedImmune, Gaithersburg, Maryland, USA.
  • Kong Y; Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Hu L; UF Brain Tumor Immunotherapy Program, Preston A. Wells Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, Florida, USA.
  • Shang Y; Fourth Section of the Department of Neurosurgery, the First Affiliated Hospital, Harbin Medical University(HMU), Harbin, China.
  • Jiang C; Fourth Section of the Department of Neurosurgery, the First Affiliated Hospital, Harbin Medical University(HMU), Harbin, China.
  • Nie J; Fourth Section of the Department of Neurosurgery, the First Affiliated Hospital, Harbin Medical University(HMU), Harbin, China.
  • Li S; Second Section of the Department of Pulmonary Medicine, the First Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Gu Y; Fourth Section of the Department of Neurosurgery, the First Affiliated Hospital, Harbin Medical University(HMU), Harbin, China.
  • Sun J; Second Section of the Department of Pulmonary Medicine, the First Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Mitchell DA; Second Section of the Department of Pulmonary Medicine, the First Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Lin Z; Second Section of the Department of Pulmonary Medicine, the First Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Huang J; Second Section of the Department of Pulmonary Medicine, the First Affiliated Hospital, Harbin Medical University, Harbin, China.
Neuro Oncol ; 20(1): 55-65, 2018 01 10.
Article en En | MEDLINE | ID: mdl-28651374
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Ligando CD27 / Receptores Quiméricos de Antígenos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Ligando CD27 / Receptores Quiméricos de Antígenos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido